Swiss regulator approves blood safety system from Cerus

08/19/2009 | Reuters

Swissmedic granted approval to Cerus' Intercept blood system, which inactivates viruses, bacteria and other blood-borne pathogens in blood components used for transfusion. The company said the approval allows Intercept-treated platelets to be stored for a week.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide